Loading people...
Gareth Groome is a Partner at Deepbridge Capital, a venture capital firm specializing in EIS and SEIS investments. He is responsible for identifying, evaluating, and supporting high-growth companies across various sectors.
Gareth Groome primarily invests in companies within the technology, life sciences, and renewable energy sectors. These investments are typically structured through Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) programs.
Gareth Groome works as a Partner at Deepbridge Capital, a leading venture capital firm based in the UK.
Gareth Groome is a distinguished Partner at Deepbridge Capital, a leading venture capital firm renowned for its expertise in EIS and SEIS investments. In his pivotal role, Gareth is instrumental in driving Deepbridge Capital's mission to connect private investors with high-growth potential businesses across the UK. His work involves a comprehensive approach, from deal origination and due diligence to portfolio management and strategic guidance for investee companies.
Deepbridge Capital, under the leadership of partners like Gareth Groome, focuses on sectors poised for significant innovation and expansion. Gareth's investment focus areas align with Deepbridge's core strategies, primarily encompassing technology, life sciences, and renewable energy. Within technology, this includes areas such as software, fintech, and advanced materials. In life sciences, his interests extend to biotech, medtech, and digital health solutions. Furthermore, his involvement in renewable energy projects underscores Deepbridge's commitment to sustainable and impactful investments.
While specific details of Gareth Groome's career background prior to Deepbridge Capital are not extensively publicized, his role as a Partner suggests a robust foundation in finance, investment management, or corporate advisory. Professionals in such senior positions typically possess a strong track record in evaluating investment opportunities, structuring deals, and fostering company growth. His expertise would likely include a deep understanding of venture capital dynamics, private equity principles, and the intricacies of EIS and SEIS tax-efficient investment schemes, which are central to Deepbridge's offerings. This background enables him to effectively navigate complex investment landscapes and identify promising ventures.
Deepbridge Capital has a strong track record of supporting innovative companies, and Gareth Groome's contributions are integral to this success. While individual partner investments are often proprietary, the firm's portfolio showcases a diverse range of successful exits and thriving businesses. Gareth's involvement ensures that Deepbridge continues to back companies that not only offer significant financial returns but also contribute to advancements in critical sectors. His strategic insights and commitment to fostering entrepreneurial success make him a key figure in the UK's venture capital ecosystem, particularly for businesses seeking EIS and SEIS funding to fuel their growth and innovation.
Gareth Groome is the Chief Financial Officer and Partner at Deepbridge Capital, a venture capital and investment management firm based in Chester, United Kingdom. In his executive capacity, he sits on the firm's Operational Partnership Board and oversees financial strategies for a portfolio managing approximately £300 million in total assets. The firm specializes in tax-efficient Enterprise Investment Scheme and Seed Enterprise Investment Scheme funds, deploying capital across early-stage technology, life sciences, and renewable energy sectors. Working alongside Managing Partner Ian Warwick and Chief Investment Officer Dr. Savvas Neophytou, Groome helps direct investments that support spinouts from 17 universities and leverage £15 million in co-funding from the British Business Investment’s Regional Angels Programme. His current professional focus centers on structuring early-stage venture capital investments to optimize tax efficiencies while funding high-growth technology and life sciences enterprises.
